IN-VITRO ACTIVITIES OF 2 NEW GLYCYLCYCLINES, N,N-DIMETHYLGLYCYLAMIDO DERIVATIVES OF MINOCYCLINE AND 6-DEMETHYL-6-DEOXYTETRACYCLINE, AGAINST339 STRAINS OF ANAEROBIC-BACTERIA
Hm. Wexler et al., IN-VITRO ACTIVITIES OF 2 NEW GLYCYLCYCLINES, N,N-DIMETHYLGLYCYLAMIDO DERIVATIVES OF MINOCYCLINE AND 6-DEMETHYL-6-DEOXYTETRACYCLINE, AGAINST339 STRAINS OF ANAEROBIC-BACTERIA, Antimicrobial agents and chemotherapy, 38(10), 1994, pp. 2513-2515
The in vitro activities of the N,N-dimethylglycylamido derivatives of
minocycline (DMG-MINO) and 6-demethyl-6-deoxytetracycline (DMG-DMDOT)
were compared with those of minocycline, tetracycline, clindamycin, an
d metronidazole by using the National Committee for Clinical Laborator
y Standards-approved Wadsworth agar dilution method. The MICs of DMG-M
INO, DMG-DMDOT, and metronidazole at which 90% of the strains mere sus
ceptible (0.5, 1, and 1 mu g/ml, respectively) were lower than those f
or clindamycin, minocycline, and tetracycline (4, 8, and 32 mu g/ml, r
espectively). All of the strains of anaerobes tested, except one strai
n of Bacteroides ovatus (MIC, 16 mu g/ml), were susceptible to DMG-MIN
O and DMG-DMDOT at 8 mu g/ml.